Project 1 - Genes to Function: Causal Genes and their Roles in Cardiomyocyte and Atrial Physiology

项目 1 - 发挥功能的基因:因果基因及其在心肌细胞和心房生理学中的作用

基本信息

  • 批准号:
    10410648
  • 负责人:
  • 金额:
    $ 50.72万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-01 至 2027-06-30
  • 项目状态:
    未结题

项目摘要

Project 1 Summary: Atrial fibrillation (AF) increases risk of heart failure, stroke and death, and its incidence increases with age and obesity. Human genome wide association studies (GWAS) have identified ~140 genetic loci associated with AF susceptibility, but it still takes dedicated functional and molecular studies to identify the causal gene, the causal genetic variant, and the mechanisms for AF association. We are very excited to pursue two AF risk loci on chromosomes 10q22 (SYNPO2L and MYOZ1 genes) and 14q23 (SYNE2 gene). We are poised to discover the mechanism by which these two loci increase AF susceptibility, and identify gene centric repurposable drugs, which may be targeted to individuals carrying these risk alleles. We chose both loci for study as the GWAS single nucleotide polymorphism (SNP) was associated with expression of a nearby gene; thus, the causal SNP, which can be in linkage disequilibrium with the GWAS SNP, may work by regulating gene expression. These associations with gene expression were for specific transcript isoforms of SYNPO2L and SYNE2 due to alternative transcription start sites. In Aim 1, we will study the complex AF locus on chromosome 10q22, where the AF risk allele is associated with decreased expression of MYOZ1, but increased expression of the shorter isoforms of SYNPO2L. Both of these genes encode Z disk proteins, which may directly affect contractility and secondarily alter Ca2+ handling that may impact cellular electrophysiology. We will study how changes in the expression of MYOZ1 and the SYPO2L isoforms alter contractility and electrophysiology in human stem cells differentiated into atrial-like cardiomyocytes (a-iCMs) and engineered heat tissue (EHT). In Aim 2, we will build on our preliminary human iCM studies, where we found that the chromosome 14q23 AF risk allele is associated with less expression of a SYNE2 short isoform. SYNE2 encodes a protein that connects the nucleus to the cytoplasm, but the short isoform does not bind to the cytoskeleton, and acts as a dominant negative to disrupt the nuclear-cytoplasm connection. RNAseq from SYNE2 short isoform overexpression in a-iCMs showed a large effect on Ca2+ handling proteins. We looked at Ca2+ handling and action potentials; knockdown of all SYNE2 isoforms led to increased early afterdepolarizations, which was rescued by over expression of the short isoform. Short isoform over expression also decreased peak Ca2+ content. We discovered that the SYNE2 short isoform also binds to the sarcoplasmic reticulum. In this aim we are poised to determine if over expression of the SYNE2 short isoform can protect against AF in a mouse model of spontaneous AF. In collaboration with SC3 and P3, Aim 3 will use the RNAseq data from Aims 1 and 2 to identify “gene effect modules”, for which we will identify module altering repurposalbe drugs, which will be tested for beneficial effects in a-iCMs and EHTs. Successful completion of our aims will make significant contributions to AF functional genomics and therapeutics.
项目1总结:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jonathan D Smith其他文献

Similar promotion of Aβ1-42 fibrillogenesis by native apolipoprotein E ε3 and ε4 isoforms
  • DOI:
    10.1186/1742-2094-1-15
  • 发表时间:
    2004-08-16
  • 期刊:
  • 影响因子:
    10.100
  • 作者:
    David Sweeney;Ralph Martins;Harry LeVine;Jonathan D Smith;Sam Gandy
  • 通讯作者:
    Sam Gandy

Jonathan D Smith的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jonathan D Smith', 18)}}的其他基金

Project 1 - Genes to Function: Causal Genes and their Roles in Cardiomyocyte and Atrial Physiology
项目 1 - 发挥功能的基因:因果基因及其在心肌细胞和心房生理学中的作用
  • 批准号:
    10646358
  • 财政年份:
    2022
  • 资助金额:
    $ 50.72万
  • 项目类别:
Genetic modifiers of atherosclerosis and macrophage phenotypes
动脉粥样硬化和巨噬细胞表型的遗传修饰
  • 批准号:
    10306932
  • 财政年份:
    2021
  • 资助金额:
    $ 50.72万
  • 项目类别:
Molecular Medicine Training Program at Cleveland Clinic/Case Western Reserve University
克利夫兰诊所/凯斯西储大学分子医学培训项目
  • 批准号:
    10426323
  • 财政年份:
    2021
  • 资助金额:
    $ 50.72万
  • 项目类别:
Molecular Medicine Training Program at Cleveland Clinic/Case Western Reserve University
克利夫兰诊所/凯斯西储大学分子医学培训项目
  • 批准号:
    10620326
  • 财政年份:
    2021
  • 资助金额:
    $ 50.72万
  • 项目类别:
Molecular Medicine Training Program at Cleveland Clinic/Case Western Reserve University
克利夫兰诊所/凯斯西储大学分子医学培训项目
  • 批准号:
    10268038
  • 财政年份:
    2021
  • 资助金额:
    $ 50.72万
  • 项目类别:
Genetic modifiers of atherosclerosis and macrophage phenotypes
动脉粥样硬化和巨噬细胞表型的遗传修饰
  • 批准号:
    10626053
  • 财政年份:
    2021
  • 资助金额:
    $ 50.72万
  • 项目类别:
Oxidant resistant apoA1 in reverse cholesterol transport, inflammation and atherosclerosis
抗氧化剂 apoA1 在逆转胆固醇转运、炎症和动脉粥样硬化中的作用
  • 批准号:
    9451333
  • 财政年份:
    2016
  • 资助金额:
    $ 50.72万
  • 项目类别:
Mechanism of ApoA1 Lipidation by ABCA1 in HDL biogenesis
HDL生物合成中ABCA1对ApoA1脂化的机制
  • 批准号:
    9102483
  • 财政年份:
    2016
  • 资助金额:
    $ 50.72万
  • 项目类别:
Oxidant resistant apoA1 in reverse cholesterol transport, inflammation and atherosclerosis
抗氧化剂 apoA1 在逆转胆固醇转运、炎症和动脉粥样硬化中的作用
  • 批准号:
    9173990
  • 财政年份:
    2016
  • 资助金额:
    $ 50.72万
  • 项目类别:
ApoA1 lipidation by ABCA1 in HDL biogenesis
HDL 生物合成中 ABCA1 对 ApoA1 脂化
  • 批准号:
    10206232
  • 财政年份:
    2016
  • 资助金额:
    $ 50.72万
  • 项目类别:

相似海外基金

A novel motility system driven by two classes of bacterial actins MreB
由两类细菌肌动蛋白 MreB 驱动的新型运动系统
  • 批准号:
    22KJ2613
  • 财政年份:
    2023
  • 资助金额:
    $ 50.72万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
The structural basis of plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
  • 批准号:
    342887
  • 财政年份:
    2016
  • 资助金额:
    $ 50.72万
  • 项目类别:
    Operating Grants
The structural basis for plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
  • 批准号:
    278338
  • 财政年份:
    2013
  • 资助金额:
    $ 50.72万
  • 项目类别:
    Operating Grants
Cytoplasmic Actins in Maintenance of Muscle Mitochondria
细胞质肌动蛋白在维持肌肉线粒体中的作用
  • 批准号:
    8505938
  • 财政年份:
    2012
  • 资助金额:
    $ 50.72万
  • 项目类别:
Differential Expression of the Diverse Plant Actins
多种植物肌动蛋白的差异表达
  • 批准号:
    7931495
  • 财政年份:
    2009
  • 资助金额:
    $ 50.72万
  • 项目类别:
Studies on how actins and microtubules are coordinated and its relevancy.
研究肌动蛋白和微管如何协调及其相关性。
  • 批准号:
    19390048
  • 财政年份:
    2007
  • 资助金额:
    $ 50.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Suppression of Arabidopsis Reproductive Actins
拟南芥生殖肌动蛋白的抑制
  • 批准号:
    6546977
  • 财政年份:
    2003
  • 资助金额:
    $ 50.72万
  • 项目类别:
Suppression of Arabidopsis Reproductive Actins
拟南芥生殖肌动蛋白的抑制
  • 批准号:
    6655612
  • 财政年份:
    2003
  • 资助金额:
    $ 50.72万
  • 项目类别:
Interaction of myosin with monomeric actins
肌球蛋白与单体肌动蛋白的相互作用
  • 批准号:
    5311554
  • 财政年份:
    2001
  • 资助金额:
    $ 50.72万
  • 项目类别:
    Priority Programmes
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
  • 批准号:
    6316669
  • 财政年份:
    2000
  • 资助金额:
    $ 50.72万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了